The trio work for Italian pharmaceuticals company Geymonat and are accused of faking and marketing the Ozopulmin drug across Italy.
“The drug has been deliberately counterfeited and is therefore dangerous to the health of babies and children,” AIFA said.
However, the AIFA stressed that batches of affected drugs were removed from the market at the start of the investigation.
The accused were arrested this morning in Latina, south of Rome, following a six-month investigation by AIFA and officers from NAS, a branch of the police force specializing in health.
The fake drugs could lead to a worsening of a patient’s respiratory condition, AIFA added.